US and Hungarian scientists say they have found an improved treatment for hepatitis B and C that is free of side effects and cheaper than currently available treatments. The treatment, to be detailed in the journal Anticancer Research, is based on the virus MTH-68/B, developed at the United Cancer Research Institute in Alexandria, Virginia. The therapy appears to halve relapse rates and costs between US$400 and $800 for a six-month course, compared to typical costs of tens of thousands of dollars for standard interferon treatments.
Hepatitis Treatment
US and Hungarian scientists say they have found an improved treatment for hepatitis B and C that is free of side effects and cheaper than currently available treatments. The treatment, to be detailed in the journal Anticancer Research, is based on the virus MTH-68/B, developed at the United Cancer Research Institute in Alexandria, Virginia. The therapy appears to halve relapse rates and costs between US$400 and $800 for a six-month course, compared to typical costs of tens of thousands of dollars for standard interferon treatments.
